EN
The future of technological innovation.
Core pipelines
  • TCR-T cell therapies against tumor-specific antigens
    TCR-T cell therapies against tumor-specific antigens
    Using high tech techniques platform such as HLA typing, tumor tissue RNA sequencing, neoantigen prediction and accurate anti-tumor TCR-T cloning, TCRCure delivers personalized TCR-T products to cater for patients with novel cancer mutations.
    Using high tech techniques platform such as HLA typing, tumor tissue RNA sequencing, neoantigen prediction and accurate anti-tumor TCR-T cloning, TCRCure delivers personalized TCR-T products to cater for patients with novel cancer mutations.
  • Memory / Exhaustion resistant CAR-T / TCR-T therapy
    Memory / Exhaustion resistant CAR-T / TCR-T therapy
    TCRCure’s unique T cell genetic engineering platform is geared to modify T cells for enhanced therapeutic potential, which includes memory T cell differentiation programs and exhaustion resistant T cell transformation programs. CAR-T and TCR-T products armed with such modifications can achieve prolonged cancer metastasis control as well as improved efficacy reach the purpose of preventing metastasis as well as improving the efficacy.
    TCRCure’s unique T cell genetic engineering platform is geared to modify T cells for enhanced therapeutic potential, which includes memory T cell differentiation programs and exhaustion resistant T cell transformation programs. CAR-T and TCR-T products armed with such modifications can achieve prolonged cancer metastasis control as well as improved efficacy reach the purpose of preventing metastasis as well as improving the efficacy.
  • Clinical immune monitoring
    Clinical immune monitoring
    TCRCure’s deep sequencing and big data analysis platform supports immune monitoring services. This service can provide valuable data to pharmaceutical companies running clinical trials on immunotherapy drugs. TCRCure has already provided this service to many well-known pharmaceutical companies including BMS.
    TCRCure’s deep sequencing and big data analysis platform supports immune monitoring services. This service can provide valuable data to pharmaceutical companies running clinical trials on immunotherapy drugs. TCRCure has already provided this service to many well-known pharmaceutical companies including BMS.
  • Generalized T cell Therapy
    Generalized T cell Therapy
    Based on the library constructed by TCRCure’s, which contains TCRs applicable to multiple cancer antigens and patients with different HLA allele, we can select the optimum tumor specific TCR and corresponding virus for the treatment of specific patients. At present, TCRCure is developing pipelines and conducting many clinical trials for multiple indications.
    Based on the library constructed by TCRCure’s, which contains TCRs applicable to multiple cancer antigens and patients with different HLA allele, we can select the optimum tumor specific TCR and corresponding virus for the treatment of specific patients. At present, TCRCure is developing pipelines and conducting many clinical trials for multiple indications.


Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
Introduction to TCRCure
Immune Cell Therapy
Product and Services
News
Recruitment

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer